LXEO
Price
$2.34
Change
-$0.30 (-11.36%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
77.68M
33 days until earnings call
RCKT
Price
$5.12
Change
-$0.44 (-7.91%)
Updated
Apr 4 closing price
Capitalization
544.88M
37 days until earnings call
Ad is loading...

LXEO vs RCKT

Header iconLXEO vs RCKT Comparison
Open Charts LXEO vs RCKTBanner chart's image
Lexeo Therapeutics
Price$2.34
Change-$0.30 (-11.36%)
Volume$1.07K
Capitalization77.68M
Rocket Pharmaceuticals
Price$5.12
Change-$0.44 (-7.91%)
Volume$4.93M
Capitalization544.88M
LXEO vs RCKT Comparison Chart
Loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXEO vs. RCKT commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXEO is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (LXEO: $2.64 vs. RCKT: $5.56)
Brand notoriety: LXEO and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXEO: 105% vs. RCKT: 245%
Market capitalization -- LXEO: $77.68M vs. RCKT: $544.88M
LXEO [@Biotechnology] is valued at $77.68M. RCKT’s [@Biotechnology] market capitalization is $544.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXEO’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • LXEO’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXEO’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • LXEO’s TA Score: 4 bullish, 5 bearish.
  • RCKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than LXEO.

Price Growth

LXEO (@Biotechnology) experienced а -35.77% price change this week, while RCKT (@Biotechnology) price change was -29.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

LXEO is expected to report earnings on May 08, 2025.

RCKT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($545M) has a higher market cap than LXEO($77.7M). RCKT YTD gains are higher at: -55.768 vs. LXEO (-59.878). LXEO has higher annual earnings (EBITDA): -84.47M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. LXEO (157M). LXEO has less debt than RCKT: LXEO (10.4M) vs RCKT (25.5M). LXEO (0) and RCKT (0) have equivalent revenues.
LXEORCKTLXEO / RCKT
Capitalization77.7M545M14%
EBITDA-84.47M-247.48M34%
Gain YTD-59.878-55.768107%
P/E RatioN/AN/A-
Revenue00-
Total Cash157M372M42%
Total Debt10.4M25.5M41%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXEORCKT
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAIVX24.37N/A
N/A
Fidelity Advisor Equity Value I
PPUMX11.60N/A
N/A
Principal LargeCap Growth I R3
WFGGX26.36N/A
N/A
First Trust WCM Focused Global Gr Inv
MNSQX21.28N/A
N/A
Invesco Main Street Small Cap R5
ACWZX16.72N/A
N/A
AMG GW&K Small/Mid Cap Growth Z

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with ARWR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-10.36%
ARWR - LXEO
42%
Loosely correlated
-4.96%
RCKT - LXEO
42%
Loosely correlated
-11.75%
PRME - LXEO
36%
Loosely correlated
-10.06%
BEAM - LXEO
36%
Loosely correlated
-10.93%
ACET - LXEO
36%
Loosely correlated
-7.32%
More